Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

By Rask Charlotte   Albertioni Freidoun   Bentzen Soeren M.   Schroeder Henrik   Peterson Curt  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite

Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma

By Mir Olivier   Ropert Stanislas   Babinet Antoine   Alexandre Jérôme   Larousserie Frédérique   Durand Jean-Philippe   Enkaoua Eric   Anract Philippe   Goldwasser François  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1059-1063

Springer Publishing Company

Access to resources Recommend Favorite

Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 3, 2016-02 ,pp. : 387-392

Bentham Science Publishers

Access to resources Recommend Favorite

High dose methotrexate in adult patients with osteosarcoma: Clinical and pharmacokinetic results

By Comandone Alessandro   Passera Roberto   Boglione Antonella   Tagini Valentina   Ferrari Stefano   Cattel Luigi  

Acta Oncologica, Vol. 44, Iss. 4, 2005-06 ,pp. : 406-411

Informa Healthcare

Access to resources Recommend Favorite

Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew   Abrey Lauren   Shah Gaurav   Panageas Katherine   Begemann Martin   Malkin Mark   Raizer Jeffrey  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite